In radiotherapy, HMGB1 both activates anti-tumor immunity and aids DNA repair, interacting with Ku70 in nasopharyngeal carcinoma and modulating the TLR4/NF-κB axis in lung cancer. This evidence concerns the gene XRCC6 and nasopharyngeal carcinoma.